- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
SMSLIFE's API facility (Unit 1, Telangana) has received its USFDA Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) status.
**The Issue:** The company's key API manufacturing facility had undergone a USFDA inspection, leading to a period of uncertainty regarding potential compliance findings and their impact on market access.
**The Impact:** The VAI status is a highly positive outcome. It affirms SMSLIFE's strong commitment to maintaining global quality standards. This is crucial as it ensures continued, unimpeded access to the vital US and other highly regulated global markets for their Active Pharmaceutical Ingredients, removing a significant regulatory overhang for the stock.
**Company's Action:** Receiving the VAI report indicates that any observations from the inspection were minor and have been successfully addressed, or only require voluntary actions from the company. This confirms their robust quality systems and mitigates potential operational or market access risks.